Feed aggregator

ASCO in Review: Oncologists See Practice-Changing, Affirming Data

Biospace news - Sun, 08/06/2023 - 02:00
ASCO in Review: Oncologists See Practice-Changing, Affirming Data 6/8/2023

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug

Biospace news - Sun, 08/06/2023 - 02:00
Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug 6/8/2023

Upstream Bio Adds Another $200M for Asthma, Allergy Pipeline

Biospace news - Sun, 08/06/2023 - 02:00
Upstream Bio Adds Another $200M for Asthma, Allergy Pipeline 6/8/2023

Bitterroot Launches with $145M Series A to Advance Cardio-Immuno Therapies

Biospace news - Sun, 08/06/2023 - 02:00
Bitterroot Launches with $145M Series A to Advance Cardio-Immuno Therapies 6/8/2023

Columbus, Cincinnati & Indianapolis Top List of Emerging Hubs for Researchers

Biospace news - Sun, 08/06/2023 - 02:00
Columbus, Cincinnati & Indianapolis Top List of Emerging Hubs for Researchers 6/8/2023

Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ...

Biospace news - Sat, 08/05/2023 - 02:00
Boehringer Ingelheim to Mine Ginkgo’s Molecules in $406M Undruggable Targets ... 5/8/2023

BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle

Biospace news - Sat, 08/05/2023 - 02:00
BioNTech Looks to Expand into Other Markets as COVID-19 Revenues Dwindle 5/8/2023

BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model

Biospace news - Sat, 08/05/2023 - 02:00
BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model 5/8/2023

Biopharma Bets Big on Antibody-Drug Conjugates

Biospace news - Sat, 08/05/2023 - 02:00
Biopharma Bets Big on Antibody-Drug Conjugates 5/8/2023

Opinion: Hope on the Horizon for Sjogren’s Syndrome

Biospace news - Sat, 08/05/2023 - 02:00
Opinion: Hope on the Horizon for Sjogren’s Syndrome 5/8/2023

FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More

Biospace news - Sat, 08/05/2023 - 02:00
FDA Action Alert: Sarepta, Protalix, Otsuka/Lundbeck and More 5/8/2023

FDA Guidance May Bolster Confidence in Decentralized Clinical Trials

Biospace news - Sat, 08/05/2023 - 02:00
FDA Guidance May Bolster Confidence in Decentralized Clinical Trials 5/8/2023

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.

Bill & Melinda Gates Foundation, Children's Investment Fund Foundation, Pfizer and Becton, Dickinson & Company expand partnership for greater access to injectable contraceptive for women in low- and lower-middle-income countries

World Pharma News - Fri, 08/04/2023 - 10:00
To help enable greater access to injectable contraceptives for millions of women in low- and lower-middle income countries, the Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (CIFF), Pfizer and Becton, Dickinson & Company (BD) announced the expansion of their nearly decade-long collaboration. The expanded collaboration is expected to deliver more than 320 million doses of Pfizer's injectable contraceptive, Sayana® Press (medroxyprogesterone acetate)(1) administered by BD Uniject™ Auto-Disable Prefillable Injection System, through 2030.